Dehydroepiandrosterone (DHEA) supplementation improves in vitro fertilization outcomes of poor ovarian responders, especially in women with low serum concentration of DHEA-S: a retrospective cohort study

• Main Authors: Chyi-Uei Chern (Author), Kuan-Hao Tsui (Author), Salvatore Giovanni Vitale (Author), San-Nung Chen (Author), Peng-Hui Wang (Author), Antonio Cianci (Author), Hsiao-Wen Tsai (Author), Zhi-Hong Wen (Author), Li-Te Lin (Author)
• Format: Book
• Published: BMC, 2018-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Dehydroepiandrosterone (DHEA) is now widely used as an adjuvant for in vitro fertilization (IVF) cycles in poor ovarian responders (PORs). Several studies showed that DHEA supplementation could improve IVF outcomes of PORs. However, most of the PORs do not respond to DHEA clinica...